Generic Name：

Formoterol Fumarate Inhalation Solution

Indications：

Formoterol Fumarate Inhalation Solution is a long-acting beta2-adrenergic agonist (beta2-agonist) indicated for: Long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Dosage Forms and Strengths

Inhalation Solution (unit dose vial for nebulization); 20 mcg/2 mL solution

Dosage and Administration：

One 20 mcg/2 mL vial every 12 hours